CHRISTINA KARR: Open Payments
NPI 1881855120 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$463 in 20 payments from 7 companies in 2025. Trend: 2023 $86 · 2024 $286 · 2025 $463
Food & beverage: $463
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $144 |
| Novartis Pharmaceuticals Corporation | 7 | $110 |
| PFIZER INC. | 5 | $86 |
| Alnylam Pharmaceuticals Inc. | 3 | $51 |
| Kestra Medical Technology Services, Inc. | 1 | $33 |
| Boston Scientific Corporation | 1 | $23 |
| Amgen Inc. | 1 | $17 |
Products named: Ozempic, LEQVIO, ELIQUIS, AMVUTTRA, Assure WCD, BodyGuardian, ENTRESTO, VYNDAQEL.
Industry payments across NC — which companies pay providers there.
